Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
Maidenhead
Open University Press
2004
|
Schriftenreihe: | European Observatory on Health Systems and Policies series
|
Schlagworte: | |
Online-Zugang: | DE-1046 DE-1047 Volltext |
Beschreibung: | Includes bibliographical references and index Regulating pharmaceuticals in Europe : an overview / Elias Mossialos, Tom Walley and Monique Mrazek -- The politics of pharmaceuticals in the European Union / Govin Permanand and Christa Altenstetter -- The European Community dimension : coordinating divergence / Leigh Hancher -- The role of the EMEA in regulating pharmaceutical products / Silvio Garattini and VIttorio Bertele' -- Measuring, monitoring and evaluating policy outcomes in the pharmaceutical sector / Panos Kanavos [and others] -- Regulating pharmaceutical prices in the European Union / Monique Mrazek and Elias Mossialos -- Reimbursement of pharmaceuticals in the European Union / Alistair McGuire, Michael Drummond and Frans Rutten -- Good prescribing practice / Steve Chapman, Pierre Durieux and Tom Walley -- Patients and their medicines / Colin Bradley, Ebba Holme Hansen and Sjoerd Kooiker -- Financial incentives and prescribing / Tom Walley and Elais Mossialos -- Regulating pharmaceutical distribution and retail pharmacy in Europe / David Taylor, Monique Mrazek and Elias Mossialos -- Hospital pharmacies / Steve Hudson -- Influencing demand for drugs through cost sharing / Sarah Thomson and Elias Mossialos -- The off-patent pharmaceutical market / Christine M. Bond [and others] -- The implications of pharmacogenetics and pharmacogenomics for drug development and health care / Munir Pirmohamed and Graham Lewis -- Should we pay for lifestyle drugs? / Tom Walley -- Alternative medicines in Europe / Edzard Ernst and Anna Dixon -- The pharmaceutical sector and regulation in the countries of Central and Eastern Europe / Monique Mrazek [and others] -- Access to pharmaceuticals and regulation in the Commonwealth of Independent States / Moninque Mrazek and Armin Fidler -- A framework for containing costs fairly / Donald W. Light and Tom Walley "This thoughtful and comprehensive book represents the best work I have seen on the current situation concerning medication policies in the EU. It is not just that this is a very up-to-date compendium of facts and data across a wide variety of domains that impact on pharmaceutical regulation. The book is also strong on analysis of those facts as well."--Jerry Avorn, Harvard Medical School. "This book offers a comprehensive examination of approaches to manage pharmaceutical expenditures in Europe. It is a must-read for those who seek to understand and navigate the changing regulatory environment for medicines in the European Union." - Bernie O'Brien, McMaster University, Canada. The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care.; "Regulating Pharmaceuticals in Europe" is an important book for students of health policy, regulation and management, and for health managers and policy makers. The editors are: Elias Mossialos is Brian Abel-Smith Professor of Health Policy at the London School of Economics and Political Science and a Research Director of the European Observatory on Health Systems and Policies. Monique Mrazek is a Health Economist (Europe and Central Asia region) for the World Bank and formerly a Research Officer in Health Economics for the European Observatory on Health Systems and Policies. Tom Walley is Professor of Clinical Pharmacology at the University of Liverpool and Director of the UK National Health Technology Assessment Programme. Contributors include: Julia Abelson, Christa Altenstetter, Vittorio Bertele', Christine Bond, Marcel L. Bouvy, Colin Bradley, Steve Chapman, Anna Dixon, Michael Drummond, Pierre Durieux, Edzard Ernst, Armin Fidler, Eric Fortess, Richard Frank, Silvio Garattini, Leigh Hancher, Ebba Holme Hansen, Steve Hudson, Kees de Jonchere, Panos Kanavos, Sjoerd Kooiker, Jean-Marc Leder, Graham Lewis, Donald W.; Light, Alistair McGuire, Elias Mossialos, Monique Mrazek, Maria Pia Orru', Govin Permanand, Guenka Petrova, Munir Pirmohamed, Dennis Ross-Degnan, Frans Rutten, Steven Soummerai, David Taylor, Sarah Thomson, and Tom Walley |
Beschreibung: | 1 Online-Ressource (xix, 368 pages) |
ISBN: | 0335214665 0335226558 1280947357 9780335214662 9780335226559 9781280947353 |
Internformat
MARC
LEADER | 00000nam a2200000zc 4500 | ||
---|---|---|---|
001 | BV043078216 | ||
003 | DE-604 | ||
007 | cr|uuu---uuuuu | ||
008 | 151126s2004 xx o|||| 00||| eng d | ||
020 | |a 0335214665 |c cased |9 0-335-21466-5 | ||
020 | |a 0335214665 |c cased |9 0-335-21466-5 | ||
020 | |a 0335226558 |c electronic bk. |9 0-335-22655-8 | ||
020 | |a 1280947357 |9 1-280-94735-7 | ||
020 | |a 9780335214662 |c cased |9 978-0-335-21466-2 | ||
020 | |a 9780335226559 |c electronic bk. |9 978-0-335-22655-9 | ||
020 | |a 9781280947353 |9 978-1-280-94735-3 | ||
035 | |a (OCoLC)191935038 | ||
035 | |a (DE-599)BVBBV043078216 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-1046 |a DE-1047 | ||
082 | 0 | |a 362.1782094 |2 22 | |
084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
245 | 1 | 0 | |a Regulating pharmaceuticals in Europe |b striving for efficiency, equity and quality |c edited by Elias Mossialos, Monique Mrazek, Tom Walley |
264 | 1 | |a Maidenhead |b Open University Press |c 2004 | |
300 | |a 1 Online-Ressource (xix, 368 pages) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a European Observatory on Health Systems and Policies series | |
500 | |a Includes bibliographical references and index | ||
500 | |a Regulating pharmaceuticals in Europe : an overview / Elias Mossialos, Tom Walley and Monique Mrazek -- The politics of pharmaceuticals in the European Union / Govin Permanand and Christa Altenstetter -- The European Community dimension : coordinating divergence / Leigh Hancher -- The role of the EMEA in regulating pharmaceutical products / Silvio Garattini and VIttorio Bertele' -- Measuring, monitoring and evaluating policy outcomes in the pharmaceutical sector / Panos Kanavos [and others] -- Regulating pharmaceutical prices in the European Union / Monique Mrazek and Elias Mossialos -- Reimbursement of pharmaceuticals in the European Union / Alistair McGuire, Michael Drummond and Frans Rutten -- Good prescribing practice / Steve Chapman, Pierre Durieux and Tom Walley -- Patients and their medicines / Colin Bradley, Ebba Holme Hansen and Sjoerd Kooiker -- Financial incentives and prescribing / Tom Walley and Elais Mossialos -- Regulating pharmaceutical distribution and retail pharmacy in Europe / David Taylor, Monique Mrazek and Elias Mossialos -- Hospital pharmacies / Steve Hudson -- Influencing demand for drugs through cost sharing / Sarah Thomson and Elias Mossialos -- The off-patent pharmaceutical market / Christine M. Bond [and others] -- The implications of pharmacogenetics and pharmacogenomics for drug development and health care / Munir Pirmohamed and Graham Lewis -- Should we pay for lifestyle drugs? / Tom Walley -- Alternative medicines in Europe / Edzard Ernst and Anna Dixon -- The pharmaceutical sector and regulation in the countries of Central and Eastern Europe / Monique Mrazek [and others] -- Access to pharmaceuticals and regulation in the Commonwealth of Independent States / Moninque Mrazek and Armin Fidler -- A framework for containing costs fairly / Donald W. Light and Tom Walley | ||
500 | |a "This thoughtful and comprehensive book represents the best work I have seen on the current situation concerning medication policies in the EU. It is not just that this is a very up-to-date compendium of facts and data across a wide variety of domains that impact on pharmaceutical regulation. The book is also strong on analysis of those facts as well."--Jerry Avorn, Harvard Medical School. "This book offers a comprehensive examination of approaches to manage pharmaceutical expenditures in Europe. It is a must-read for those who seek to understand and navigate the changing regulatory environment for medicines in the European Union." - Bernie O'Brien, McMaster University, Canada. The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. | ||
500 | |a Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care.; "Regulating Pharmaceuticals in Europe" is an important book for students of health policy, regulation and management, and for health managers and policy makers. The editors are: Elias Mossialos is Brian Abel-Smith Professor of Health Policy at the London School of Economics and Political Science and a Research Director of the European Observatory on Health Systems and Policies. Monique Mrazek is a Health Economist (Europe and Central Asia region) for the World Bank and formerly a Research Officer in Health Economics for the European Observatory on Health Systems and Policies. | ||
500 | |a Tom Walley is Professor of Clinical Pharmacology at the University of Liverpool and Director of the UK National Health Technology Assessment Programme. Contributors include: Julia Abelson, Christa Altenstetter, Vittorio Bertele', Christine Bond, Marcel L. Bouvy, Colin Bradley, Steve Chapman, Anna Dixon, Michael Drummond, Pierre Durieux, Edzard Ernst, Armin Fidler, Eric Fortess, Richard Frank, Silvio Garattini, Leigh Hancher, Ebba Holme Hansen, Steve Hudson, Kees de Jonchere, Panos Kanavos, Sjoerd Kooiker, Jean-Marc Leder, Graham Lewis, Donald W.; Light, Alistair McGuire, Elias Mossialos, Monique Mrazek, Maria Pia Orru', Govin Permanand, Guenka Petrova, Munir Pirmohamed, Dennis Ross-Degnan, Frans Rutten, Steven Soummerai, David Taylor, Sarah Thomson, and Tom Walley | ||
610 | 2 | 7 | |a Europäische Union |0 (DE-588)5098525-5 |2 gnd |9 rswk-swf |
650 | 7 | |a MEDICAL / Allied Health Services / General |2 bisacsh | |
650 | 7 | |a Drugs / Law and legislation |2 fast | |
650 | 7 | |a Drugs / Prescribing |2 fast | |
650 | 7 | |a Pharmaceutical industry |2 fast | |
650 | 7 | |a Pharmaceutical policy |2 fast | |
650 | 7 | |a Farmaceutische industrie |2 gtt | |
650 | 7 | |a Regulering |2 gtt | |
650 | 4 | |a Drug and Narcotic Control / legislation and jurisprudence / Europe | |
650 | 4 | |a Legislation, Drug / Europe | |
650 | 4 | |a Medizin | |
650 | 4 | |a Recht | |
650 | 4 | |a Pharmaceutical industry |z Europe | |
650 | 4 | |a Drugs |x Law and legislation |z Europe | |
650 | 4 | |a Drugs |x Prescribing |z Europe | |
650 | 4 | |a Pharmaceutical policy |z Europe | |
650 | 0 | 7 | |a Regulierung |0 (DE-588)4201190-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
651 | 4 | |a Europa | |
689 | 0 | 0 | |a Europäische Union |0 (DE-588)5098525-5 |D b |
689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
689 | 0 | 2 | |a Regulierung |0 (DE-588)4201190-5 |D s |
689 | 0 | |8 1\p |5 DE-604 | |
700 | 1 | |a Mossialos, Elias |e Sonstige |4 oth | |
700 | 1 | |a Mrazek, Monique Francine |e Sonstige |4 oth | |
700 | 1 | |a Walley, Tom |e Sonstige |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 0-335-21465-7 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 0-335-21465-7 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 978-0-335-21465-5 |
856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=234041 |x Aggregator |3 Volltext |
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
912 | |a ZDB-4-EBA | ||
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-028502408 | |
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=234041 |l DE-1046 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=234041 |l DE-1047 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext |
Datensatz im Suchindex
_version_ | 1820137809543954432 |
---|---|
adam_text | |
any_adam_object | |
building | Verbundindex |
bvnumber | BV043078216 |
classification_rvk | QR 525 |
collection | ZDB-4-EBA |
ctrlnum | (OCoLC)191935038 (DE-599)BVBBV043078216 |
dewey-full | 362.1782094 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 362 - Social problems and services to groups |
dewey-raw | 362.1782094 |
dewey-search | 362.1782094 |
dewey-sort | 3362.1782094 |
dewey-tens | 360 - Social problems and services; associations |
discipline | Soziologie Wirtschaftswissenschaften |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zc 4500</leader><controlfield tag="001">BV043078216</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2004 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0335214665</subfield><subfield code="c">cased</subfield><subfield code="9">0-335-21466-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0335214665</subfield><subfield code="c">cased</subfield><subfield code="9">0-335-21466-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0335226558</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-335-22655-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1280947357</subfield><subfield code="9">1-280-94735-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780335214662</subfield><subfield code="c">cased</subfield><subfield code="9">978-0-335-21466-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780335226559</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-335-22655-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781280947353</subfield><subfield code="9">978-1-280-94735-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)191935038</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043078216</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.1782094</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Regulating pharmaceuticals in Europe</subfield><subfield code="b">striving for efficiency, equity and quality</subfield><subfield code="c">edited by Elias Mossialos, Monique Mrazek, Tom Walley</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Maidenhead</subfield><subfield code="b">Open University Press</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xix, 368 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">European Observatory on Health Systems and Policies series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Regulating pharmaceuticals in Europe : an overview / Elias Mossialos, Tom Walley and Monique Mrazek -- The politics of pharmaceuticals in the European Union / Govin Permanand and Christa Altenstetter -- The European Community dimension : coordinating divergence / Leigh Hancher -- The role of the EMEA in regulating pharmaceutical products / Silvio Garattini and VIttorio Bertele' -- Measuring, monitoring and evaluating policy outcomes in the pharmaceutical sector / Panos Kanavos [and others] -- Regulating pharmaceutical prices in the European Union / Monique Mrazek and Elias Mossialos -- Reimbursement of pharmaceuticals in the European Union / Alistair McGuire, Michael Drummond and Frans Rutten -- Good prescribing practice / Steve Chapman, Pierre Durieux and Tom Walley -- Patients and their medicines / Colin Bradley, Ebba Holme Hansen and Sjoerd Kooiker -- Financial incentives and prescribing / Tom Walley and Elais Mossialos -- Regulating pharmaceutical distribution and retail pharmacy in Europe / David Taylor, Monique Mrazek and Elias Mossialos -- Hospital pharmacies / Steve Hudson -- Influencing demand for drugs through cost sharing / Sarah Thomson and Elias Mossialos -- The off-patent pharmaceutical market / Christine M. Bond [and others] -- The implications of pharmacogenetics and pharmacogenomics for drug development and health care / Munir Pirmohamed and Graham Lewis -- Should we pay for lifestyle drugs? / Tom Walley -- Alternative medicines in Europe / Edzard Ernst and Anna Dixon -- The pharmaceutical sector and regulation in the countries of Central and Eastern Europe / Monique Mrazek [and others] -- Access to pharmaceuticals and regulation in the Commonwealth of Independent States / Moninque Mrazek and Armin Fidler -- A framework for containing costs fairly / Donald W. Light and Tom Walley</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"This thoughtful and comprehensive book represents the best work I have seen on the current situation concerning medication policies in the EU. It is not just that this is a very up-to-date compendium of facts and data across a wide variety of domains that impact on pharmaceutical regulation. The book is also strong on analysis of those facts as well."--Jerry Avorn, Harvard Medical School. "This book offers a comprehensive examination of approaches to manage pharmaceutical expenditures in Europe. It is a must-read for those who seek to understand and navigate the changing regulatory environment for medicines in the European Union." - Bernie O'Brien, McMaster University, Canada. The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care.; "Regulating Pharmaceuticals in Europe" is an important book for students of health policy, regulation and management, and for health managers and policy makers. The editors are: Elias Mossialos is Brian Abel-Smith Professor of Health Policy at the London School of Economics and Political Science and a Research Director of the European Observatory on Health Systems and Policies. Monique Mrazek is a Health Economist (Europe and Central Asia region) for the World Bank and formerly a Research Officer in Health Economics for the European Observatory on Health Systems and Policies.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Tom Walley is Professor of Clinical Pharmacology at the University of Liverpool and Director of the UK National Health Technology Assessment Programme. Contributors include: Julia Abelson, Christa Altenstetter, Vittorio Bertele', Christine Bond, Marcel L. Bouvy, Colin Bradley, Steve Chapman, Anna Dixon, Michael Drummond, Pierre Durieux, Edzard Ernst, Armin Fidler, Eric Fortess, Richard Frank, Silvio Garattini, Leigh Hancher, Ebba Holme Hansen, Steve Hudson, Kees de Jonchere, Panos Kanavos, Sjoerd Kooiker, Jean-Marc Leder, Graham Lewis, Donald W.; Light, Alistair McGuire, Elias Mossialos, Monique Mrazek, Maria Pia Orru', Govin Permanand, Guenka Petrova, Munir Pirmohamed, Dennis Ross-Degnan, Frans Rutten, Steven Soummerai, David Taylor, Sarah Thomson, and Tom Walley</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Allied Health Services / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Law and legislation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Prescribing</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical industry</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical policy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmaceutische industrie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Regulering</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug and Narcotic Control / legislation and jurisprudence / Europe</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Legislation, Drug / Europe</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="z">Europe</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">Europe</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Prescribing</subfield><subfield code="z">Europe</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical policy</subfield><subfield code="z">Europe</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Regulierung</subfield><subfield code="0">(DE-588)4201190-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">Europa</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Regulierung</subfield><subfield code="0">(DE-588)4201190-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mossialos, Elias</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mrazek, Monique Francine</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Walley, Tom</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">0-335-21465-7</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">0-335-21465-7</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">978-0-335-21465-5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=234041</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028502408</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=234041</subfield><subfield code="l">DE-1046</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=234041</subfield><subfield code="l">DE-1047</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
geographic | Europa |
geographic_facet | Europa |
id | DE-604.BV043078216 |
illustrated | Not Illustrated |
indexdate | 2025-01-02T11:51:21Z |
institution | BVB |
isbn | 0335214665 0335226558 1280947357 9780335214662 9780335226559 9781280947353 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028502408 |
oclc_num | 191935038 |
open_access_boolean | |
owner | DE-1046 DE-1047 |
owner_facet | DE-1046 DE-1047 |
physical | 1 Online-Ressource (xix, 368 pages) |
psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
publishDate | 2004 |
publishDateSearch | 2004 |
publishDateSort | 2004 |
publisher | Open University Press |
record_format | marc |
series2 | European Observatory on Health Systems and Policies series |
spelling | Regulating pharmaceuticals in Europe striving for efficiency, equity and quality edited by Elias Mossialos, Monique Mrazek, Tom Walley Maidenhead Open University Press 2004 1 Online-Ressource (xix, 368 pages) txt rdacontent c rdamedia cr rdacarrier European Observatory on Health Systems and Policies series Includes bibliographical references and index Regulating pharmaceuticals in Europe : an overview / Elias Mossialos, Tom Walley and Monique Mrazek -- The politics of pharmaceuticals in the European Union / Govin Permanand and Christa Altenstetter -- The European Community dimension : coordinating divergence / Leigh Hancher -- The role of the EMEA in regulating pharmaceutical products / Silvio Garattini and VIttorio Bertele' -- Measuring, monitoring and evaluating policy outcomes in the pharmaceutical sector / Panos Kanavos [and others] -- Regulating pharmaceutical prices in the European Union / Monique Mrazek and Elias Mossialos -- Reimbursement of pharmaceuticals in the European Union / Alistair McGuire, Michael Drummond and Frans Rutten -- Good prescribing practice / Steve Chapman, Pierre Durieux and Tom Walley -- Patients and their medicines / Colin Bradley, Ebba Holme Hansen and Sjoerd Kooiker -- Financial incentives and prescribing / Tom Walley and Elais Mossialos -- Regulating pharmaceutical distribution and retail pharmacy in Europe / David Taylor, Monique Mrazek and Elias Mossialos -- Hospital pharmacies / Steve Hudson -- Influencing demand for drugs through cost sharing / Sarah Thomson and Elias Mossialos -- The off-patent pharmaceutical market / Christine M. Bond [and others] -- The implications of pharmacogenetics and pharmacogenomics for drug development and health care / Munir Pirmohamed and Graham Lewis -- Should we pay for lifestyle drugs? / Tom Walley -- Alternative medicines in Europe / Edzard Ernst and Anna Dixon -- The pharmaceutical sector and regulation in the countries of Central and Eastern Europe / Monique Mrazek [and others] -- Access to pharmaceuticals and regulation in the Commonwealth of Independent States / Moninque Mrazek and Armin Fidler -- A framework for containing costs fairly / Donald W. Light and Tom Walley "This thoughtful and comprehensive book represents the best work I have seen on the current situation concerning medication policies in the EU. It is not just that this is a very up-to-date compendium of facts and data across a wide variety of domains that impact on pharmaceutical regulation. The book is also strong on analysis of those facts as well."--Jerry Avorn, Harvard Medical School. "This book offers a comprehensive examination of approaches to manage pharmaceutical expenditures in Europe. It is a must-read for those who seek to understand and navigate the changing regulatory environment for medicines in the European Union." - Bernie O'Brien, McMaster University, Canada. The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care.; "Regulating Pharmaceuticals in Europe" is an important book for students of health policy, regulation and management, and for health managers and policy makers. The editors are: Elias Mossialos is Brian Abel-Smith Professor of Health Policy at the London School of Economics and Political Science and a Research Director of the European Observatory on Health Systems and Policies. Monique Mrazek is a Health Economist (Europe and Central Asia region) for the World Bank and formerly a Research Officer in Health Economics for the European Observatory on Health Systems and Policies. Tom Walley is Professor of Clinical Pharmacology at the University of Liverpool and Director of the UK National Health Technology Assessment Programme. Contributors include: Julia Abelson, Christa Altenstetter, Vittorio Bertele', Christine Bond, Marcel L. Bouvy, Colin Bradley, Steve Chapman, Anna Dixon, Michael Drummond, Pierre Durieux, Edzard Ernst, Armin Fidler, Eric Fortess, Richard Frank, Silvio Garattini, Leigh Hancher, Ebba Holme Hansen, Steve Hudson, Kees de Jonchere, Panos Kanavos, Sjoerd Kooiker, Jean-Marc Leder, Graham Lewis, Donald W.; Light, Alistair McGuire, Elias Mossialos, Monique Mrazek, Maria Pia Orru', Govin Permanand, Guenka Petrova, Munir Pirmohamed, Dennis Ross-Degnan, Frans Rutten, Steven Soummerai, David Taylor, Sarah Thomson, and Tom Walley Europäische Union (DE-588)5098525-5 gnd rswk-swf MEDICAL / Allied Health Services / General bisacsh Drugs / Law and legislation fast Drugs / Prescribing fast Pharmaceutical industry fast Pharmaceutical policy fast Farmaceutische industrie gtt Regulering gtt Drug and Narcotic Control / legislation and jurisprudence / Europe Legislation, Drug / Europe Medizin Recht Pharmaceutical industry Europe Drugs Law and legislation Europe Drugs Prescribing Europe Pharmaceutical policy Europe Regulierung (DE-588)4201190-5 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Europa Europäische Union (DE-588)5098525-5 b Arzneimittel (DE-588)4003115-9 s Regulierung (DE-588)4201190-5 s 1\p DE-604 Mossialos, Elias Sonstige oth Mrazek, Monique Francine Sonstige oth Walley, Tom Sonstige oth Erscheint auch als Druck-Ausgabe, Paperback 0-335-21465-7 Erscheint auch als Druck-Ausgabe, Paperback 978-0-335-21465-5 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=234041 Aggregator Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Regulating pharmaceuticals in Europe striving for efficiency, equity and quality Europäische Union (DE-588)5098525-5 gnd MEDICAL / Allied Health Services / General bisacsh Drugs / Law and legislation fast Drugs / Prescribing fast Pharmaceutical industry fast Pharmaceutical policy fast Farmaceutische industrie gtt Regulering gtt Drug and Narcotic Control / legislation and jurisprudence / Europe Legislation, Drug / Europe Medizin Recht Pharmaceutical industry Europe Drugs Law and legislation Europe Drugs Prescribing Europe Pharmaceutical policy Europe Regulierung (DE-588)4201190-5 gnd Arzneimittel (DE-588)4003115-9 gnd |
subject_GND | (DE-588)5098525-5 (DE-588)4201190-5 (DE-588)4003115-9 |
title | Regulating pharmaceuticals in Europe striving for efficiency, equity and quality |
title_auth | Regulating pharmaceuticals in Europe striving for efficiency, equity and quality |
title_exact_search | Regulating pharmaceuticals in Europe striving for efficiency, equity and quality |
title_full | Regulating pharmaceuticals in Europe striving for efficiency, equity and quality edited by Elias Mossialos, Monique Mrazek, Tom Walley |
title_fullStr | Regulating pharmaceuticals in Europe striving for efficiency, equity and quality edited by Elias Mossialos, Monique Mrazek, Tom Walley |
title_full_unstemmed | Regulating pharmaceuticals in Europe striving for efficiency, equity and quality edited by Elias Mossialos, Monique Mrazek, Tom Walley |
title_short | Regulating pharmaceuticals in Europe |
title_sort | regulating pharmaceuticals in europe striving for efficiency equity and quality |
title_sub | striving for efficiency, equity and quality |
topic | Europäische Union (DE-588)5098525-5 gnd MEDICAL / Allied Health Services / General bisacsh Drugs / Law and legislation fast Drugs / Prescribing fast Pharmaceutical industry fast Pharmaceutical policy fast Farmaceutische industrie gtt Regulering gtt Drug and Narcotic Control / legislation and jurisprudence / Europe Legislation, Drug / Europe Medizin Recht Pharmaceutical industry Europe Drugs Law and legislation Europe Drugs Prescribing Europe Pharmaceutical policy Europe Regulierung (DE-588)4201190-5 gnd Arzneimittel (DE-588)4003115-9 gnd |
topic_facet | Europäische Union MEDICAL / Allied Health Services / General Drugs / Law and legislation Drugs / Prescribing Pharmaceutical industry Pharmaceutical policy Farmaceutische industrie Regulering Drug and Narcotic Control / legislation and jurisprudence / Europe Legislation, Drug / Europe Medizin Recht Pharmaceutical industry Europe Drugs Law and legislation Europe Drugs Prescribing Europe Pharmaceutical policy Europe Regulierung Arzneimittel Europa |
url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=234041 |
work_keys_str_mv | AT mossialoselias regulatingpharmaceuticalsineuropestrivingforefficiencyequityandquality AT mrazekmoniquefrancine regulatingpharmaceuticalsineuropestrivingforefficiencyequityandquality AT walleytom regulatingpharmaceuticalsineuropestrivingforefficiencyequityandquality |